Apotex's generic Ozempic (Semaglutide Injection) receives US FDA tentative approval

Lupin's Dapagliflozin Tablets launched in US market

AnBogen Therapeutics to present Imofinostat (ABT-301) breakthroughs at AACR 2026

Verastem Oncology presents two-year follow-up data on avutometinib and defactinib in recurrent low-grade serous ovarian cancer

DualityBio reports China NMPA acceptance of BLA for T-Pam for treatment of unresectable or metastatic HER2-positive breast cancer

Oricell Therapeutics completes USD110m pre-IPO financing

Tempus expands oncology collaboration with Gilead to accelerate AI-driven R&D

Eli Lilly launches Foundayo weight‑loss pill in the US

Solvonis Therapeutics secures second US patent for PTSD compound series

GSK secures China approval for Exdensur to treat nasal polyp condition

Coiled Therapeutics reports enhanced efficacy for AO-252 and accelerates transition to dose expansion

IDEOlogy Health and West Cancer Center partner to advance patient-centred oncology education and care

Lupin's Dapagliflozin Tablets receive US regulatory approval

Insmed reports Phase 2b study of brensocatib did not meet efficacy endpoints

Dexcel Pharma's Nintedanib Capsules approved for US launch